Neurodegenerative disease: MRI biomarkers - a precision medicine tool in neurology?

Journal: Nature reviews. Neurology
Published Date:

Abstract

Two new studies highlight the potential of neuroimaging to aid the differential diagnosis of neurodegenerative disease, for both clinical practice and emerging trials. Although this approach holds great promise, meaningful implementation of neuroimaging as part of a tailored precision medicine strategy may require additional imaging and non-imaging biomarkers.

Authors

  • Corey T McMillan
    Department of Neurology, Penn Frontotemporal Degeneration Center, Hospital of the University of Pennsylvania, 3400 Spruce Street, 3 West Gates, Philadelphia, Pennsylvania 19104, USA.